サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1320232

がん幹細胞市場：がん形態別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Cancer Stem Cells Market with COVID-19 Impact Analysis, By Cancer Forms, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 359 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
がん幹細胞市場：がん形態別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 359 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

がん幹細胞の市場規模は2022年に10億5,670万米ドルと評価され、2023年から2030年にかけてCAGR 9.1％で拡大

がん幹細胞市場-市場力学：

がん疾患の有病率の増加と幹細胞研究への投資の増加ががん幹細胞の需要を促進すると予想されます。

がん幹細胞市場は、世界のがん罹患率の上昇から大きな影響を受けています。がんが世界の死因の上位を占め続ける中、がん幹細胞を用いた研究や治療法の重要性が増しています。幹細胞研究、特にがん幹細胞への資金調達や投資の増加により、新たな発見や革新的な治療法の創出が加速しています。非営利財団、営利企業、政府機関のすべてがこの拡大に貢献しています。ゲノミクス、分子生物学、免疫療法の分野の発展により、がん幹細胞や、腫瘍の発生や進行におけるその機能についての理解が深まっています。

製薬企業は、がん幹細胞を特異的に標的とする新しい治療法を開発するために、臨床試験やがん幹細胞に関する研究に資金を提供しています。臨床試験の結果が良好であれば、市場の拡大に拍車がかかります。臨床試験は、将来性のある医薬品の安全性と有効性を確認するために極めて重要です。

がん幹細胞市場-主要洞察：

  • がん幹細胞産業は、動物の健康と栄養への注目の高まりにより、著しい速度で成長すると予測されます。
  • 用途別では、標的がん幹細胞セグメントが2022年に最大市場シェアを示すと予測されました。
  • がんの形態に基づくと、乳がんセグメントが2022年にリードしています。
  • 地域別では、北米が2022年の売上高をリードしています。

がん幹細胞市場-セグメンテーション分析：

世界のがん幹細胞市場は、がんの形態、用途、システム、地域に基づいてセグメント化されます。

がんの形態によって、乳がん、血液がん、脳腫瘍、肺がん、膵臓がん、膀胱がん、その他がんの7つに分類されます。

市場は用途別に2つのカテゴリーに分類される：標的がん幹細胞、幹細胞ベースのがん治療。標的がん幹細胞分野が市場を独占しています。小型幹細胞の普及拡大が市場成長を後押しすると期待されています。

がん幹細胞市場-地理的洞察：

地理的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

がん幹細胞市場-競合情勢：

がん幹細胞市場に影響を与えるのは、ヘルスケアと遺伝子工学の進歩の増加です。アプリケーションプロバイダーを含むヘルスケア施設は、がん治療、評判、入手可能性など様々な要因で競争しています。企業が市場参入とシェア拡大のために用いる主な手法や戦略には、新製品の発売、研究開発費、流通網の開拓、M&Aなどがあります。最近の動向の一部を以下に紹介します。

最近の動き

2022年6月、BlueRock Therapeutics社は、欧州における臨床能力を強化するため、ドイツに新たな細胞治療施設を導入しました。

調査の主な特徴

  • この調査レポートは、がん幹細胞市場の市場規模、複合年間成長率（CAGR %）、2022年を基準年とした推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、がん幹細胞市場に関する最新動向の洞察を顧客に提供します。
  • 調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、がん幹細胞市場の魅力的な投資提案マトリクスを説明します。
  • がん幹細胞市場における新たな投資機会、既存企業が直面する課題、持続的な成長要因を明らかにします。
  • がん幹細胞市場規模、予測、CAGR、市場力学に対するCOVID-19の影響について調査範囲で詳細に考察COVID後のがん幹細胞市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーにがん幹細胞市場の包括的な見解を提供するために、がん幹細胞市場の競合情勢と主要イノベーター分析も含めています。
  • 本レポートでは、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークした成長展望マッピング分析を掲載しています。
  • 本レポートでは、主要市場参入企業の詳細な企業プロファイルを掲載しており、がん幹細胞市場で事業を展開する企業の財務状況や戦略的イニシアチブを理解するのに役立ちます。
  • 加えて、本レポートは、世界レベルだけでなく地域レベルで市場に関わる主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。
  • がん幹細胞の世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 がん幹細胞市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 がん幹細胞の主要な市場動向

  • がん幹細胞市場促進要因
  • がん幹細胞市場抑制要因
  • がん幹細胞市場の機会
  • がん幹細胞市場の将来動向

第4章 がん幹細胞産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 がん幹細胞市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 がん幹細胞市場情勢

  • がん幹細胞市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 がん幹細胞市場- がん形態別

  • 概要
    • がん形態別セグメントシェア分析
    • 胸
    • 血
    • 脳
    • 肺
    • 膵臓
    • 膀胱
    • その他

第8章 がん幹細胞市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 標的がん性幹細胞
    • 幹細胞に基づくがん治療

第9章 がん幹細胞市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • がん幹細胞の北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • がん幹細胞の欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域のがん幹細胞の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • がん幹細胞ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカのがん幹細胞の主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- がん幹細胞産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • AbbVie, Inc.
    • Merck KGaA
    • Bionomics
    • Lonza
    • Stemline Therapeutics, Inc.
    • Miltenyi Biotec
    • PromoCell GmbH
    • MacroGenics, Inc
    • OncoMed Pharmaceuticals, Inc.
    • Irvine Scientific
    • STEMCELL Technologies Inc.
    • BlueRock Therapeutics
    • Sino Biological Inc.
    • Biotime Inc.

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Stem Cells Market: Cancer Forms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Forms
  • TABLE Global Cancer Stem Cells Market, by Cancer Forms 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Cancer Stem Cells Market, by Product 2018-2030 (USD Million)
  • TABLE Cancer Stem Cells Market: Regional snapshot (2022)
  • TABLE Cancer Stem Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Stem Cells Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Stem Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Cancer Forms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Stem Cells Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Stem Cells Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Cancer Forms segment market share analysis, 2022 & 2030
  • FIGURE Cancer Forms segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Europe Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Latin America Cancer Stem Cells Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Stem Cells Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Germany Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE India Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Brazil Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Stem Cells Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Stem Cells Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1543

REPORT HIGHLIGHT

Cancer Stem Cells Market size was valued at USD 1,056.7 Million in 2022, expanding at a CAGR of 9.1% from 2023 to 2030.

A subgroup of cells having stem cell-like characteristics that are present in tumors are known as cancer stem cells. They have the same capacity for self-renewal and cell cancer forms differentiation as regular stem cells. However, cancer stem cells are tumorigenic, meaning they can give rise to new cancer cells and aid in the spread of disease, in contrast to normal stem cells.

Cancer Stem Cells Market- Market Dynamics:

Growing prevalence of cancer diseases and rising investment in stem cell research is expected to propel the cancer stem cells demand.

The market for cancer stem cells has been significantly influenced by the rising incidence of cancer across the world. Research and treatments involving cancer stem cells are becoming more important as cancer continues to be the leading cause of death worldwide. The rate of new discoveries and the creation of innovative therapies has accelerated due to increased financing and investment in stem cell research, especially cancer stem cells. Nonprofit foundations, for-profit businesses, and government agencies have all contributed to this expansion. Understanding cancer stem cells and their function in tumor initiation and progression has improved because of developments in the fields of genomics, molecular biology, and immunotherapy.

Pharmaceutical corporations are funding clinical trials and research into cancer stem cells to create novel treatments that specifically target these cells. Positive trial outcomes can spur market expansion. Clinical studies are crucial for confirming the security and effectiveness of prospective medicines.

Cancer Stem Cells Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Stem Cells market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2023-2030)
  • The Cancer Stem Cells industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Application, targeted cancerous stem cells segment was predicted to show maximum market share in the year 2022.
  • Based on Cancer Forms, segmentation, breast cancer segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Cancer Stem Cells Market- Segmentation Analysis:

The Global Cancer Stem Cells Market is segmented on the basis of Cancer Forms, Application, System, and Region.

The market is divided into seven categories based on Cancer Forms: breast, blood, brain, lung, pancreatic, bladder, and others. The rocket launchers segment dominates the market. Increasing demand rocket launching system is contributing to market growth.

The market is divided into two categories based on Application: targeted cancerous stem cells, and stem-cell based cancer therapy. The targeted cancerous stem cells segment dominates the market. Growing prevalence of small stem cells is expected to boost the market growth.

Cancer Stem Cells Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Cancer Stem Cells Market- Competitive Landscape:

Owing to the increasing advancement in healthcare and genetic engineering, which influence the Cancer Stem Cells market. Healthcare facilities including application providers compete on various factors, such as cancer therapy, reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In June 2022, BlueRock Therapeutics has introduced new cell treatment site in Germany to enhance its clinical capabilities in Europe.

Key features of the study:

  • This proposed research study on Cancer Stem Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Stem Cells market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Stem Cells market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Stem Cells market
  • Impact of COVID-19 on Cancer Stem Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Stem Cells market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Stem Cells market, we have also included competitive landscape and key innovator analysis for the Cancer Stem Cells market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Cancer Stem Cells market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Stem Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER STEM CELLS MARKET KEY PLAYERS

  • Thermo Fisher Scientific, Inc.
  • AbbVie, Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics, Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics, Inc
  • OncoMed Pharmaceuticals, Inc.
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • BlueRock Therapeutics
  • Sino Biological Inc.
  • Biotime Inc.

GLOBAL CANCER STEM CELLS MARKET, BY CANCER FORMS

  • Breast
  • Blood
  • Brain
  • Lung
  • Pancreatic
  • Bladder
  • Others

GLOBAL CANCER STEM CELLS MARKET, BY APPLICATION

  • Targeted Cancerous Stem Cells
  • Stem-cell based Cancer Therapy

GLOBAL CANCER STEM CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Stem Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Stem Cells Market Snippet by Cancer Forms
    • 2.1.2. Cancer Stem Cells Market Snippet by Application
    • 2.1.3. Cancer Stem Cells Market Snippet by Country
    • 2.1.4. Cancer Stem Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Stem Cells Key Market Trends

  • 3.1. Cancer Stem Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Stem Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Stem Cells Market Opportunities
  • 3.4. Cancer Stem Cells Market Future Trends

4. Cancer Stem Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Stem Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Stem Cells Market Landscape

  • 6.1. Cancer Stem Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Stem Cells Market - By Cancer Forms

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Cancer Forms, 2022 & 2030 (%)
    • 7.1.2. Breast
    • 7.1.3. Blood
    • 7.1.4. Brain
    • 7.1.5. Lung
    • 7.1.6. Pancreatic
    • 7.1.7. Bladder
    • 7.1.8. Others

8. Cancer Stem Cells Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Targeted Cancerous Stem Cells
    • 8.1.3. Stem-cell based Cancer Therapy

9. Cancer Stem Cells Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Cancer Stem Cells Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.6.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.7.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Cancer Stem Cells Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.11.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.14.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Cancer Stem Cells Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. China Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. South Korea Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Australia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Australia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Indonesia
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Indonesia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Philippines
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Philippines Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.15. Rest of APAC
      • 9.4.15.1. Overview
      • 9.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.15.3. Rest of APAC Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Cancer Stem Cells Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Brazil Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Mexico Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Argentina Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Colombia
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Colombia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.11. Rest of LATAM
      • 9.5.11.1. Overview
      • 9.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.11.3. Rest of LATAM Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Cancer Stem Cells Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. Saudi Arabia Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. United Arab Emirates Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Israel
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Israel Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Turkey
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Turkey Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Algeria
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Algeria Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Egypt
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Egypt Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.13. Rest of MEA
      • 9.6.13.1. Overview
      • 9.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.13.3. Rest of MEA Market Size and Forecast, By Cancer Forms, 2018 - 2030 (US$ Million)
      • 9.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Cancer Stem Cells Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific, Inc.
    • 10.2.2. AbbVie, Inc.
    • 10.2.3. Merck KGaA
    • 10.2.4. Bionomics
    • 10.2.5. Lonza
    • 10.2.6. Stemline Therapeutics, Inc.
    • 10.2.7. Miltenyi Biotec
    • 10.2.8. PromoCell GmbH
    • 10.2.9. MacroGenics, Inc
    • 10.2.10. OncoMed Pharmaceuticals, Inc.
    • 10.2.11. Irvine Scientific
    • 10.2.12. STEMCELL Technologies Inc.
    • 10.2.13. BlueRock Therapeutics
    • 10.2.14. Sino Biological Inc.
    • 10.2.15. Biotime Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us